[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]

October 2019 - July 1883

Decade

Year

Issue

May 3, 2016, Vol 315, No. 17, Pages 1811-1920

In This Issue of JAMA

Highlights

Abstract Full Text
free access has audio
JAMA. 2016;315(17):1811-1813. doi:10.1001/jama.2015.14240
Original Investigation

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial

Abstract Full Text
free access has audio
JAMA. 2016;315(17):1844-1853. doi:10.1001/jama.2016.4324

This randomized trial compares the effects of induction gemcitabine with vs without erlotinib in patients with locally advanced pancreatic cancer and, among those responsive to treatment, compares the effects of chemotherapy with vs without radiation.

Effect of a Web-Based Guided Self-help Intervention for Prevention of Major Depression in Adults With Subthreshold Depression: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA. 2016;315(17):1854-1863. doi:10.1001/jama.2016.4326

This randomized clinical trial compares the effects of a web-based guided self-help intervention vs enhanced usual care for prevention of major depressive disorder among adults with subthreshold depression.

Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011

Abstract Full Text
free access
JAMA. 2016;315(17):1864-1873. doi:10.1001/jama.2016.4151

This pharmacoepidemiology study estimates the rate of outpatient, oral antibiotic prescribing by age and diagnosis in the United States and the estimated portion of antibiotic use that may be inappropriate in adults and children.

Association Between Availability of a Price Transparency Tool and Outpatient Spending

Abstract Full Text
free access
JAMA. 2016;315(17):1874-1881. doi:10.1001/jama.2016.4288

This study investigated whether an employer-sponsored health care price transparency tool was associated with lower employee outpatient spending.

Research Letter

Infections in Early Life and Development of Type 1 Diabetes

Abstract Full Text
free access
JAMA. 2016;315(17):1899-1901. doi:10.1001/jama.2016.2181

This population epidemiology study uses regional claims data from Germany to investigate associations between infections in the first 2 years of life and development of type 1 diabetes.

Viewpoint

Patient Safety at the Crossroads

Abstract Full Text
JAMA. 2016;315(17):1829-1830. doi:10.1001/jama.2016.1759

This Viewpoint discusses the National Patient Safety Foundation’s report Free From Harm: Accelerating Patient Safety Improvement 15 Years AfterTo Err Is Human” and whether the recommendations achieve total systems safety.

Toward a Safer Health Care System: The Critical Need to Improve Measurement

Abstract Full Text
JAMA. 2016;315(17):1831-1832. doi:10.1001/jama.2016.3448

This Viewpoint discusses how policy makers might develop and implement standardized, validated metrics to track the progress of patient safety improvements.

Eliminating the Term Primary Care “Provider”: Consequences of Language for the Future of Primary Care

Abstract Full Text
JAMA. 2016;315(17):1833-1834. doi:10.1001/jama.2016.2329

This Viewpoint discusses issues related to the use of “provider” to describe primary care health professionals with varying levels of training and certification and the effects of these issues on quality of care.

A Piece of My Mind

Tasteless Insights

Abstract Full Text
JAMA. 2016;315(17):1835-1836. doi:10.1001/jama.2015.18355
Editorial

Optimizing Treatment for Locally Advanced Pancreas Cancer: Progress but No Precision

Abstract Full Text
JAMA. 2016;315(17):1837-1838. doi:10.1001/jama.2016.4284

Addressing the Appropriateness of Outpatient Antibiotic Prescribing in the United States: An Important First Step

Abstract Full Text
JAMA. 2016;315(17):1839-1841. doi:10.1001/jama.2016.4286

Price Transparency: Not a Panacea for High Health Care Costs

Abstract Full Text
JAMA. 2016;315(17):1842-1843. doi:10.1001/jama.2016.4325
Review

Pancreatic Cyst Disease: A Review

Abstract Full Text
JAMA. 2016;315(17):1882-1893. doi:10.1001/jama.2016.4690

This narrative review summarizes types of pancreatic cysts and management strategies for each based on a synthesis of the published literature.

From the JAMA Network

Recognizing Sun Safety as an Employee Health Issue

Abstract Full Text
JAMA. 2016;315(17):1894-1895. doi:10.1001/jama.2016.1008

This commentary discusses a survey study published in JAMA Dermatology that investigated whether government organizations in Colorado had occupational sun protection policies.

JAMA Clinical Challenge

An Elderly Unresponsive Patient

Abstract Full Text
JAMA. 2016;315(17):1896-1897. doi:10.1001/jama.2016.4462

A 79-year-old man with a history of hypertension and stroke presented to the emergency department unresponsive with an undetectable temperature. Blood pressure was 85/55 mm Hg; pulse oximetry was 100% on ambient air. An ECG revealed sinus bradycardia with Osborn waves and attenuated P waves. What would you do next?

Medical News & Perspectives

Twenty Years After Folic Acid Fortification, FDA Ponders Expansion to Corn Masa Flour

Abstract Full Text
JAMA. 2016;315(17):1821-1822. doi:10.1001/jama.2016.2611

This Medical News & Perspectives article discusses the role of folic acid fortification of cereal grain products in reducing the risk of infant neural tube defects, as well as a push to allow voluntary fortification of corn masa flour.

News From the Food and Drug Administration

New Salvo Against Opioid Abuse

Abstract Full Text
JAMA. 2016;315(17):1826. doi:10.1001/jama.2016.4409

Boxed Warning for Most Opioids

Abstract Full Text
JAMA. 2016;315(17):1826. doi:10.1001/jama.2016.4482

Treating and Preventing Anthrax

Abstract Full Text
JAMA. 2016;315(17):1826. doi:10.1001/jama.2016.4484
The JAMA Forum

Cultural Influences Reflected in Divergent US vs UK Human Embryo Research Policies

Abstract Full Text
free access
JAMA. 2016;315(17):1822-1823. doi:10.1001/jama.2016.3020
JAMA Infographic

Visualizing Health Policy

Eligibility and Coverage Trends in Employer-Sponsored Insurance

Abstract Full Text
free access
JAMA. 2016;315(17):1824. doi:10.1001/jama.2016.3992
Lab Reports

Dengue Vaccine Performs Well in Small Clinical Trial

Abstract Full Text
JAMA. 2016;315(17):1825. doi:10.1001/jama.2016.4339

Nanoparticle Strategy Enhances Delivery of Cancer Drugs

Abstract Full Text
JAMA. 2016;315(17):1825. doi:10.1001/jama.2016.4946

Diet-Induced Obesity and Diabetes Can Be Epigenetically Inherited

Abstract Full Text
JAMA. 2016;315(17):1825. doi:10.1001/jama.2016.4948
The Art of JAMA

Market in San Miguel: Lew Davis

Abstract Full Text
JAMA. 2016;315(17):1818-1819. doi:10.1001/jama.2015.14242
Poetry and Medicine

Weights and Measures

Abstract Full Text
JAMA. 2016;315(17):1908. doi:10.1001/jama.2015.19392
JAMA Revisited

Cooperation in Social Insurance Investigation

Abstract Full Text
JAMA. 2016;315(17):1909. doi:10.1001/jama.2015.17084
JAMA Patient Page

Dietary Guidelines for Americans—Eat Less Saturated Fat

Abstract Full Text
free access
JAMA. 2016;315(17):1919-1920. doi:10.1001/jama.2016.0972
Comment & Response

Noninvasive Ventilation and Outcomes Among Immunocompromised Patients

Abstract Full Text
JAMA. 2016;315(17):1901-1902. doi:10.1001/jama.2016.0674

Noninvasive Ventilation and Outcomes Among Immunocompromised Patients

Abstract Full Text
JAMA. 2016;315(17):1902. doi:10.1001/jama.2016.0677

Noninvasive Ventilation and Outcomes Among Immunocompromised Patients—Reply

Abstract Full Text
JAMA. 2016;315(17):1902-1903. doi:10.1001/jama.2016.0692

The Undiagnosed Diseases Program

Abstract Full Text
JAMA. 2016;315(17):1903-1904. doi:10.1001/jama.2016.0443

The Undiagnosed Diseases Program—Reply

Abstract Full Text
JAMA. 2016;315(17):1904. doi:10.1001/jama.2016.0454

Treatment of Patients With Stable Ischemic Heart Disease

Abstract Full Text
JAMA. 2016;315(17):1904-1905. doi:10.1001/jama.2016.0680

Treatment of Patients With Stable Ischemic Heart Disease

Abstract Full Text
JAMA. 2016;315(17):1905. doi:10.1001/jama.2016.0683

Treatment of Patients With Stable Ischemic Heart Disease—Reply

Abstract Full Text
JAMA. 2016;315(17):1905-1906. doi:10.1001/jama.2016.0698

Treatment of Patients With Stable Ischemic Heart Disease—Reply

Abstract Full Text
JAMA. 2016;315(17):1906-1907. doi:10.1001/jama.2016.0695
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2016;315(17):1815-1816. doi:10.1001/jama.2015.14241
×